Norco, categorized by the FDA as being a Timetable III managed material for short-expression pain administration, carries a potential for addiction and is associated with significant toxicity, notably causing liver injury. To scale back the potential risk of respiratory depression, appropriate dosing and titration of NORCO is critical [see DOSAGE https://nonprescriptionsmedsonline.com/product/lortab/